Detalles de la búsqueda
1.
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.
Oncotarget
; 9(29): 20339-20350, 2018 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755655
2.
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.
Oncotarget
; 9(41): 26279-26290, 2018 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29899858
Resultados
1 -
2
de 2
1
Próxima >
>>